Medical Packaging Company (EGX:MEPA)
Egypt · Delayed Price · Currency is EGP 1.950
-0.100 (-4.88%)
At close: Sep 14, 2026
Medical Packaging Company Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,277 | 1,225 | 806 | 597 | 123 | 128 | |
Market Cap Growth | 47.73% | 52.03% | 35.02% | 385.84% | -4.04% | -37.33% |
Enterprise Value | 1,218 | 1,145 | 728 | 578 | 132 | 150 |
Last Close Price | 1.95 | 1.87 | 1.23 | 0.91 | 0.36 | 0.32 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 122.87 | 50.55 | 22.03 | 28.28 | 21.41 | 16.67 |
PS Ratio | 13.03 | 10.23 | 6.15 | 6.56 | 2.07 | 2.72 |
PB Ratio | 5.83 | 5.58 | 4.12 | 3.69 | 1.56 | 1.75 |
P/TBV Ratio | 5.83 | 5.58 | 4.12 | 3.69 | 1.56 | 1.75 |
P/FCF Ratio | - | - | 96.51 | 90.25 | 5.24 | 12.79 |
P/OCF Ratio | 56.91 | 53.82 | 33.36 | 86.94 | 4.99 | 12.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 12.43 | 9.56 | 5.56 | 6.35 | 2.23 | 3.18 |
EV/EBITDA Ratio | 87.03 | 41.24 | 19.24 | 14.28 | 6.65 | 11.80 |
EV/EBIT Ratio | 166.55 | 55.66 | 22.29 | 16.33 | 8.49 | 16.62 |
EV/FCF Ratio | - | - | 87.19 | 87.47 | 5.63 | 14.94 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.11 | 0.14 | 0.01 | 0.01 | 0.03 | 0.24 |
Debt / EBITDA Ratio | 1.76 | 1.09 | 0.06 | 0.03 | 0.10 | 1.38 |
Debt / FCF Ratio | - | - | 0.29 | 0.20 | 0.09 | 1.75 |
Net Debt / Equity Ratio | -0.27 | -0.22 | -0.34 | -0.37 | -0.12 | 0.24 |
Net Debt / EBITDA Ratio | -4.21 | -1.77 | -1.75 | -1.48 | -0.46 | 1.36 |
Net Debt / FCF Ratio | 4.46 | 3.23 | -7.94 | -9.09 | -0.39 | 1.72 |
Asset Turnover | 0.38 | 0.47 | 0.62 | 0.59 | 0.52 | 0.44 |
Inventory Turnover | 1.55 | 1.70 | 3.09 | 2.87 | 3.53 | 3.81 |
Quick Ratio | 2.65 | 2.61 | 3.64 | 5.76 | 1.00 | 0.64 |
Current Ratio | 4.17 | 4.28 | 5.68 | 7.30 | 1.57 | 1.03 |
Return on Equity (ROE) | 4.86% | 11.68% | 20.47% | 17.54% | 7.56% | 11.10% |
Return on Assets (ROA) | 1.76% | 5.02% | 9.64% | 14.23% | 8.51% | 5.24% |
Return on Invested Capital (ROIC) | 3.08% | 11.16% | 20.50% | 33.38% | 6.12% | 9.08% |
Return on Capital Employed (ROCE) | 3.10% | 8.60% | 15.80% | 20.40% | 17.10% | 11.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.81% | 1.98% | 4.54% | 3.54% | 4.67% | 6.00% |
FCF Yield | -1.04% | -1.24% | 1.04% | 1.11% | 19.10% | 7.82% |
Buyback Yield / Dilution | - | - | - | -89.85% | - | - |